Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Strengthening provider-initiated testing and counselling in Zimbabwe by deploying supplemental providers: a time series analysis.

Bochner AF, Tippett Barr BA, Makunike B, Gonese G, Wazara B, Mashapa R, Meacham E, Nyika P, Ncube G, Balachandra S, Levine R, Petracca F, Apollo T, Downer A, Wiktor SZ.

BMC Health Serv Res. 2019 Jun 3;19(1):351. doi: 10.1186/s12913-019-4169-z.

2.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts T, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ; Lancet Gastroenterology & Hepatology Commissioners.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):135-184. doi: 10.1016/S2468-1253(18)30270-X. Review. Erratum in: Lancet Gastroenterol Hepatol. 2019 May;4(5):e4.

PMID:
30647010
3.

Viral Hepatitis.

Wiktor SZ.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 16.

4.

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.

Lazarus JV, Safreed-Harmon K, Thursz MR, Dillon JF, El-Sayed MH, Elsharkawy AM, Hatzakis A, Jadoul M, Prestileo T, Razavi H, Rockstroh JK, Wiktor SZ, Colombo M.

Semin Liver Dis. 2018 Aug;38(3):181-192. doi: 10.1055/s-0038-1666841. Epub 2018 Jul 9. Review.

PMID:
29986353
5.

What is the impact of treatment for hepatitis C virus infection?

Wiktor SZ, Scott JD.

Lancet. 2017 Jul 8;390(10090):107-109. doi: 10.1016/S0140-6736(17)31762-2. No abstract available.

PMID:
28699578
6.

Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses.

Hutin YJ, Wiktor SZ.

Gut. 2017 Dec;66(12):2052-2053. doi: 10.1136/gutjnl-2016-312636. Epub 2016 Aug 26. No abstract available.

PMID:
27566128
7.

The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.

Wiktor SZ, Hutin YJ.

Lancet. 2016 Sep 10;388(10049):1030-1031. doi: 10.1016/S0140-6736(16)31018-2. Epub 2016 Jul 7. No abstract available.

PMID:
27394646
8.

Global policy and access to new hepatitis C therapies for people who inject drugs.

Doyle JS, Aspinall EJ, Hutchinson SJ, Quinn B, Gore C, Wiktor SZ, Hellard ME.

Int J Drug Policy. 2015 Nov;26(11):1064-71. doi: 10.1016/j.drugpo.2015.05.008. Epub 2015 Jun 2. Review.

PMID:
26118794
9.

Deciding who should be treated for hepatitis C infection in a rapidly changing therapeutic landscape.

Wiktor SZ.

Hepatology. 2015 Jul;62(1):13-5. doi: 10.1002/hep.27810. Epub 2015 May 29. No abstract available.

PMID:
25820452
10.

Where next for hepatitis B and C surveillance?

Wiktor SZ.

J Viral Hepat. 2015 Jul;22(7):571-3. doi: 10.1111/jvh.12400. Epub 2015 Mar 6. Review.

PMID:
25754464
11.

World health organization approaches to evaluating the potential use and quality of hepatitis e vaccine.

Harmanci H, Duclos P, Rodriguez Hernandez CA, Meek A, Balakrishnan MR, Kumar Arora N, Wiktor SZ.

Open Forum Infect Dis. 2014 Dec 2;1(3):ofu099. doi: 10.1093/ofid/ofu099. eCollection 2014 Dec. No abstract available.

12.

Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis.

Aspinall EJ, Doyle JS, Corson S, Hellard ME, Hunt D, Goldberg D, Nguyen T, Falck-Ytter Y, Morgan RL, Smith B, Stoove M, Wiktor SZ, Hutchinson S.

Eur J Epidemiol. 2015 Feb;30(2):115-29. doi: 10.1007/s10654-014-9958-4. Epub 2014 Nov 11. Review.

13.

A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region.

Itani T, Jacobsen KH, Nguyen T, Wiktor SZ.

Vaccine. 2014 Oct 21;32(46):6067-74. doi: 10.1016/j.vaccine.2014.09.006. Epub 2014 Sep 16. Review.

PMID:
25236586
14.

Evaluation of using routine infant immunization visits to identify and follow-up HIV-exposed infants and their mothers in Tanzania.

Goodson JL, Finkbeiner T, Davis NL, Lyimo D, Rwebembera A, Swartzendruber AL, Wallace AS, Kimambo S, Kimario CJ, Wiktor SZ, Luman ET.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):e9-e15. doi: 10.1097/QAI.0b013e31828a3e3f.

PMID:
23406977
15.

Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis.

Becquet R, Marston M, Dabis F, Moulton LH, Gray G, Coovadia HM, Essex M, Ekouevi DK, Jackson D, Coutsoudis A, Kilewo C, Leroy V, Wiktor SZ, Nduati R, Msellati P, Zaba B, Ghys PD, Newell ML; UNAIDS Child Survival Group.

PLoS One. 2012;7(2):e28510. doi: 10.1371/journal.pone.0028510. Epub 2012 Feb 23.

16.

Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy.

Abimbola TO, Marston BJ, Date AA, Blandford JM, Sangrujee N, Wiktor SZ.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):e1-7. doi: 10.1097/QAI.0b013e318246538f.

PMID:
22240465
17.

Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study.

Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, Sissoko M, Greenberg AE, Wiktor SZ, Chorba TL.

BMC Infect Dis. 2010 Aug 17;10:242. doi: 10.1186/1471-2334-10-242.

18.

Faithfulness to partners: a means to prevent HIV infection, a source of HIV infection risks, or both? A qualitative study of women's experiences in Abidjan, Côte d'Ivoire.

Painter TM, Diaby KL, Matia DM, Lin LS, Sibailly TS, Kouassi MK, Ekpini ER, Roels TH, Wiktor SZ.

Afr J AIDS Res. 2007 Apr;6(1):25-31. doi: 10.2989/16085900709490396.

PMID:
25875342
19.

Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.

McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, Wiktor SZ.

AIDS. 2005 May;19 Suppl 2:S25-30. Review.

PMID:
15930838
20.

Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire.

Painter TM, Diaby KL, Matia DM, Lin LS, Sibailly TS, Kouassims MK, Ekpini ER, Roels TH, Wiktor SZ.

Int J STD AIDS. 2005 Mar;16(3):237-42.

PMID:
15829025
21.

Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.

Kalou M, Sassan-Morokro M, Abouya L, Bile C, Maurice C, Maran M, Tossou O, Roels T, Greenberg AE, Wiktor SZ, Nkengasong JN.

J Med Virol. 2005 Feb;75(2):202-8.

PMID:
15602734
22.
23.

Effect of an HIV counseling and testing program on AIDS-related knowledge and practices in tuberculosis clinics in Abidjan, Côte d'Ivoire.

Wiktor SZ, Abouya L, Angoran H, McFarland J, Sassan-Morokro M, Tossou O, Coulibaly D, Coulibaly IM, Greenberg AE.

Int J Tuberc Lung Dis. 2004 Apr;8(4):445-50.

PMID:
15141737
24.

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.

Pieniazek D, Rayfield M, Hu DJ, Nkengasong JN, Soriano V, Heneine W, Zeh C, Agwale SM, Wambebe C, Odama L, Wiktor SZ.

AIDS. 2004 Feb 20;18(3):495-502.

PMID:
15090802
25.

Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire.

Koblavi-Dème S, Kestens L, Hanson D, Otten RA, Borget MY, Bilé C, Wiktor SZ, Roels TH, Chorba T, Nkengasong JN.

AIDS. 2004 Feb 20;18(3):413-9.

PMID:
15090792
26.

HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire.

Jamieson DJ, Sibailly TS, Sadek R, Roels TH, Ekpini ER, Boni-Ouattara E, Karon JM, Nkengasong J, Greenberg AE, Wiktor SZ.

J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):430-6.

PMID:
14615662
27.

A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children.

Maloney EM, Wiktor SZ, Palmer P, Cranston B, Pate EJ, Cohn S, Kim N, Miley W, Thomas TL, Blattner WA, Hanchard B.

Pediatrics. 2003 Aug;112(2):e136-42.

PMID:
12897319
28.

Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa.

Leroy V, Karon JM, Alioum A, Ekpini ER, van de Perre P, Greenberg AE, Msellati P, Hudgens M, Dabis F, Wiktor SZ; West Africa PMTCT Study Group.

AIDS. 2003 Jul 4;17(10):1493-501.

PMID:
12824787
29.

Assessment of the validity of and adherence to sexually transmitted infection algorithms at a female sex worker clinic in Abidjan, Côte d'Ivoire.

Vuylsteke BL, Ettiègne-Traore V, Anoma CK, Bandama C, Ghys PD, Maurice CE, Van Dyck E, Wiktor SZ, Laga M.

Sex Transm Dis. 2003 Apr;30(4):284-91.

PMID:
12671546
30.

Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa.

Leroy V, Karon JM, Alioum A, Ekpini ER, Meda N, Greenberg AE, Msellati P, Hudgens M, Dabis F, Wiktor SZ; West Africa PMTCT Study Group.

AIDS. 2002 Mar 8;16(4):631-41.

PMID:
11873008
31.

Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine.

Ekpini RA, Nkengasong JN, Sibailly T, Maurice C, Adjé C, Monga BB, Roels TH, Greenberg AE, Wiktor SZ.

AIDS. 2002 Mar 8;16(4):625-30.

PMID:
11873007
32.

Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991-1998.

Ghys PD, Diallo MO, Ettiègne-Traoré V, Kalé K, Tawil O, Caraël M, Traoré M, Mah-Bi G, De Cock KM, Wiktor SZ, Laga M, Greenberg AE.

AIDS. 2002 Jan 25;16(2):251-8.

PMID:
11807310
33.

Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

Bélec L, Ghys PD, Hocini H, Nkengasong JN, Tranchot-Diallo J, Diallo MO, Ettiègne-Traore V, Maurice C, Becquart P, Matta M, Si-Mohamed A, Chomont N, Coulibaly IM, Wiktor SZ, Kazatchkine MD.

J Infect Dis. 2001 Dec 1;184(11):1412-22. Epub 2001 Nov 13.

PMID:
11709783
34.

Is drinking water in Abidjan, Côte d'Ivoire, safe for infant formula?

Dunne EF, Angoran-Bénié H, Kamelan-Tano A, Sibailly TS, Monga BB, Kouadio L, Roels TH, Wiktor SZ, Lackritz EM, Mintz ED, Luby S.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):393-8.

PMID:
11707678
35.

Where do sex workers go for health care? A community based study in Abidjan, Côte d'Ivoire.

Vuylsteke B, Ghys PD, Mah-bi G, Konan Y, Traoré M, Wiktor SZ, Laga M.

Sex Transm Infect. 2001 Oct;77(5):351-2.

36.

Distribution of HIV-1 plasma RNA viral load and CD4 + T-cell counts among HIV-infected Africans evaluated for antiretroviral therapy.

Nkengasong JN, Borget MY, Maurice C, Boateng E, Kalou M, Djomand G, Ekpini R, Eholie S, Bissagene E, Coulibaly M, Wiktor SZ, Roels TH, Chorba T.

J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):99-101. No abstract available.

PMID:
11579285
37.

Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers.

Ghys PD, Diallo MO, Ettiègne-Traoré V, Satten GA, Anoma CK, Maurice C, Kadjo JC, Coulibaly IM, Wiktor SZ, Greenberg AE, Laga M.

AIDS. 2001 Jul 27;15(11):1421-31.

PMID:
11504964
38.

Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV-1 plasma RNA viral load and immune activation among HIV-1 seropositive female workers in Abidjan, Côte d'Ivoire.

Adjé CA, Bilé CE, Kestens L, Koblavi-Deme S, Ghys PD, Maurice C, Kalou-Badirou M, Kabran N, Ekpini RE, Roels TH, Wiktor SZ, Nkengasong JN.

J Med Virol. 2001 Aug;64(4):398-401.

PMID:
11468722
39.

High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.

Adjé C, Cheingsong R, Roels TH, Maurice C, Djomand G, Verbiest W, Hertogs K, Larder B, Monga B, Peeters M, Eholie S, Bissagene E, Coulibaly M, Respess R, Wiktor SZ, Chorba T, Nkengasong JN; UNAIDS HIV Drug Access Initiative, Abidjan, Côte d'Ivoire.

J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):501-6.

PMID:
11391173
40.

Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast.

Koblavi-Dème S, Maurice C, Yavo D, Sibailly TS, N'guessan K, Kamelan-Tano Y, Wiktor SZ, Roels TH, Chorba T, Nkengasong JN.

J Clin Microbiol. 2001 May;39(5):1808-12.

41.

Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Côte d'Ivoire.

Nkengasong JN, Kestens L, Ghys PD, Koblavi-Dème S, Bilé C, Kalou M, Ya LK, Traoré-Ettiègne V, Maurice C, Laga M, Wiktor SZ, Greenberg AE.

J Infect Dis. 2001 May 1;183(9):1405-8. Epub 2001 Mar 16.

PMID:
11294674
42.

Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast.

Nkengasong JN, Kestens L, Ghys PD, Koblavi-Dème S, Otten RA, Bilé C, Maurice C, Kalou M, Laga M, Wiktor SZ, Greenberg AE.

AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1371-8.

PMID:
11018856
43.

Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group.

Pieniazek D, Rayfield M, Hu DJ, Nkengasong J, Wiktor SZ, Downing R, Biryahwaho B, Mastro T, Tanuri A, Soriano V, Lal R, Dondero T.

AIDS. 2000 Jul 28;14(11):1489-95.

PMID:
10983635
44.

Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections.

Shanmugam V, Switzer WM, Nkengasong JN, García-Lerma G, Green TA, Ekpini E, Sassan-Morokro M, Antunes F, Manshino K, Soriano V, Wiktor SZ, Heneine W.

J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):257-63.

PMID:
10969350
45.

Human T cell lymphotropic virus type I-associated infective dermatitis in Jamaica: a case report of clinical and biologic correlates.

Maloney EM, Hisada M, Palmer P, Brooks K, Pate E, Wiktor SZ, Lagrenade L, Manns A.

Pediatr Infect Dis J. 2000 Jun;19(6):560-5. No abstract available.

PMID:
10877174
46.

Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Côte d'Ivoire.

Nkengasong JN, Luo CC, Abouya L, Pieniazek D, Maurice C, Sassan-Morokro M, Ellenberger D, Hu DJ, Pau CP, Dobbs T, Respess R, Coulibaly D, Coulibaly IM, Wiktor SZ, Greenberg AE, Rayfield M.

J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):430-6.

PMID:
10866237
47.

Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Côte d'Ivoire.

Kassim S, Zuber P, Wiktor SZ, Diomande FV, Coulibaly IM, Coulibaly D, Kadio A, Yapi A, Touré KC, Blekou PB, Irié B, Greenberg AE, Binkin NJ.

Int J Tuberc Lung Dis. 2000 Apr;4(4):321-6.

PMID:
10777080
48.

Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire.

Ghys PD, Bélec L, Diallo MO, Ettiègne-Traoré V, Becquart P, Maurice C, Nkengasong JN, Coulibaly IM, Greenberg AE, Laga M, Wiktor SZ.

AIDS. 2000 Nov 10;14(16):2603-8.

PMID:
11101074
49.

HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners.

Vernon SD, Unger ER, Piper MA, Severin ST, Wiktor SZ, Ghys PD, Miller DL, Horowitz IR, Greenberg AE, Reeves WC.

Sex Transm Infect. 1999 Aug;75(4):258-60.

50.

Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners.

Piper MA, Severin ST, Wiktor SZ, Unger ER, Ghys PD, Miller DL, Horowitz IR, Greenberg AE, Reeves WC, Vernon SD.

Sex Transm Infect. 1999 Aug;75(4):253-7.

Supplemental Content

Loading ...
Support Center